XML 74 R58.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Tax Expense (Narrative) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Feb. 03, 2016
Operating Loss Carryforwards [Line Items]        
U.S. Federal statutory rate to net income (loss) before taxes 34.00%      
Deferred tax assets, valuation allowance $ 133,784 $ 67,172    
Change in valuation allowance 66,600      
Net change in valuation allowance, recorded as tax expense 35,678 10,052 $ 8,930  
Deferred tax asset related to compensation benefits as well as Federal and State net operating loss carryforwards 10,300      
Decrease in net operating loss carryforwards (124,881) (66,280)    
Decrease in research and development credits (21,374) (8,948)    
Undistributed earnings of foreign subsidiaries 119      
Provision for income taxes $ 498 $ (9,337) $ (62)  
Effective tax rate 0.32%      
Internal Revenue Service (IRS)        
Operating Loss Carryforwards [Line Items]        
Operating loss carryforwards, domestic $ 300,400      
Internal Revenue Service (IRS) | Research Tax Credit Carryforward        
Operating Loss Carryforwards [Line Items]        
Tax credit carryforward amount 9,000      
State and Local Jurisdiction        
Operating Loss Carryforwards [Line Items]        
Operating loss carryforwards, state and local 185,200      
State and Local Jurisdiction | Research Tax Credit Carryforward        
Operating Loss Carryforwards [Line Items]        
Tax credit carryforward amount 13,400      
Income Tax Expense (Benefit)        
Operating Loss Carryforwards [Line Items]        
Net change in valuation allowance, recorded as tax expense 35,700      
TriVascular Technologies, Inc. | Income Tax Expense (Benefit)        
Operating Loss Carryforwards [Line Items]        
Net change in valuation allowance, recorded as tax expense $ 30,900      
Scenario, Adjustment | TriVascular Technologies, Inc.        
Operating Loss Carryforwards [Line Items]        
Decrease in research and development credits       $ 3,100
Scenario, Adjustment | TriVascular Technologies, Inc. | State and Local Jurisdiction        
Operating Loss Carryforwards [Line Items]        
Decrease in net operating loss carryforwards       210,600
Scenario, Adjustment | TriVascular Technologies, Inc. | Domestic Tax Authority        
Operating Loss Carryforwards [Line Items]        
Decrease in net operating loss carryforwards       $ 230,300